Skip to content

Clinical trials

Completed Pancreatic Neoplasms trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pancreatic Neoplasms Status: Completed Country / region: Singapore Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20051
20084
20092
20111
20132
20142
20161
20171
20201
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche3
Changi General Hospital2
Al-Azhar University1
Array Biopharma, now a wholly owned subsidiary of Pfizer1
Bayer1
Boehringer Ingelheim1
Celgene1
NCIC Clinical Trials Group1
NanoCarrier Co., Ltd.1
National Cancer Centre, Singapore1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pancreatic Neoplasms18
Neoplasms3
Pancreatic Diseases3
Adenocarcinoma2
Cholangiocarcinoma2
Digestive System Diseases2
Digestive System Neoplasms2
Endocrine Gland Neoplasms2
Endocrine System Diseases2
Neoplasms by Site2

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.